CPPED1
Serine/threonine-protein phosphatase CPPED1
Also known as: CPPED_HUMAN, CSTP1, FLJ11151
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRF8
- Gene
- CPPED1
- Ensembl
- ENSG00000103381
- Chromosome
- 16
- Canonical length
- 314 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable metal ion binding activity and phosphoprotein phosphatase activity. Predicted to be involved in chromatin remodeling and regulation of transcription by RNA polymerase II. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q9BRF8|CPPED1
1 MSAAEAGGVF HRARGRTLAA FPAEKESEWK GPFYFILGAD PQFGLIKAWS TGDCDNGGDE
61 WEQEIRLTEQ AVQAINKLNP KPKFFVLCGD LIHAMPGKPW RTEQTEDLKR VLRAVDRAIP
121 LVLVSGNHDI GNTPTAETVE EFCRTWGDDY FSFWVGGVLF LVLNSQFYEN PSKCPSLKQA
181 QDQWLDEQLS IARQRHCQHA IVFQHIPLFL ESIDEDDDYY FNLSKSTRKK LADKFIHAGV
241 KVVFSGHYHR NAGGTYQNLD MVVSSAIGCQ LGRDPHGLRV VVVTAEKIVH RYYSLDELSE
301 KGIEDDLMDL IKKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPPED1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- liver: 32 nTPM
- kidney: 31 nTPM
- spleen: 28 nTPM
- esophagus: 24 nTPM
- small intestine: 20 nTPM
- duodenum: 20 nTPM
Single-cell type
- neutrophils: 1,636 nCPM
- esophageal apical cells: 388 nCPM
- monocytes: 304 nCPM
- syncytiotrophoblasts: 255 nCPM
- renal collecting duct intercalated cells: 211 nCPM
- sertoli cells: 203 nCPM
Immune cell
- neutrophil: 676 nTPM
- non-classical monocyte: 322 nTPM
- intermediate monocyte: 320 nTPM
- classical monocyte: 224 nTPM
- myeloid DC: 169 nTPM
- eosinophil: 146 nTPM
Brain region
- white matter: 29 nTPM
- medulla oblongata: 24 nTPM
- pons: 24 nTPM
- basal ganglia: 23 nTPM
- hypothalamus: 22 nTPM
- midbrain: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.96
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Calcineurin-like, phosphoesterase domain
- Metallo-dependent phosphatase-like
- Calcineurin-like phosphoesterase
- CPPED1, metallophosphatase domain
- Serine/threonine-protein phosphatase CPPED1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPPED1 as an antibody target. Whether an autoantibody or antibody against CPPED1 could matter depends on whether native CPPED1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPPED1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CPPED1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...